Cancer medicine · 2026
Tobacco Use, Knowledge of Harms, and Treatment Support Among Patients With Non-Tobacco-Related Cancers: A Multi-Center Survey Study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gregg-Garcia Raul, Dandu Vidya, Vater Laura B, Hudmon Karen Suchanek, Buckles Deborah, Hanna Nasser
Аннотация
PURPOSE: Tobacco smoking adversely affects cancer outcomes; yet tobacco treatment for patients with non-tobacco-related cancers (non-TRCs) remains understudied. This study evaluated smoking behaviors, harm perceptions, and cessation support in this population.
METHODS: We conducted a cross-sectional survey of 124 adults who reported smoking within the past 30 days and were diagnosed with non-TRCs at two medical centers between 2018 and 2022. Data collected included demographics, smoking behaviors, harm perceptions, quit attempts, and receipt of cessation support from oncology providers.
RESULTS: Most participants (88%) recognized that continued smoking may shorten life expectancy; however, fewer recognized its impact on cancer recurrence (44%), treatment efficacy (46%), and treatment-related side effects (46%). Although 81% reported prior quit attempts, only 33% received prescription medication and 22% received counseling. Follow-up support from oncology teams was reported by 42% of participants.
CONCLUSION: Patients with non-TRCs demonstrate substantial gaps in awareness of the cancer-specific harms of continued smoking and report inconsistent receipt of evidence-based cessation support. Targeted education and systematic integration of tobacco treatment into oncology care are needed to improve outcomes in this population.
METHODS: We conducted a cross-sectional survey of 124 adults who reported smoking within the past 30 days and were diagnosed with non-TRCs at two medical centers between 2018 and 2022. Data collected included demographics, smoking behaviors, harm perceptions, quit attempts, and receipt of cessation support from oncology providers.
RESULTS: Most participants (88%) recognized that continued smoking may shorten life expectancy; however, fewer recognized its impact on cancer recurrence (44%), treatment efficacy (46%), and treatment-related side effects (46%). Although 81% reported prior quit attempts, only 33% received prescription medication and 22% received counseling. Follow-up support from oncology teams was reported by 42% of participants.
CONCLUSION: Patients with non-TRCs demonstrate substantial gaps in awareness of the cancer-specific harms of continued smoking and report inconsistent receipt of evidence-based cessation support. Targeted education and systematic integration of tobacco treatment into oncology care are needed to improve outcomes in this population.